Biotechnological drugs

Application of new methods for analyzing the safety of biopharmaceuticals – Mario Martínez Popeti

Are environmental conditions harmful for biological drugs? – Alejandro Martín Rodríguez

Combatting bacteria with very small molecules of silver-DNA – Carmen López Chamorro

Desing and development of peptide-oligonucleotide conjugates for activating frataxin expression – Ricardo Chueca

Do the Moderna and Pfizer vaccines remain stable after handling during administration? – Airan Braulio Alonso García

Functionalisation of frataxin with shuttle peptides to enhance its transport to the central nervous system – Beatriz Marin

How to evaluate safety in biotechnological drugs? – Julio Ruiz

Optimizing nivolumab (Opdivo®) storage and in-use conditions through structural characterization – Francisco Ávila

Quantitative stability analysis of nivolumab, an anti-tumour drug – Lorena Jiménez Morán

Stability analysis of ipilimumab, a drug used to treat cancer – Alberto Aguilera Ortega

The use of peptides to prevent binding between CD47 and SIRPα proteins in order to avoid infections – Paula Quesada Martínez